Back to Search
DAVID G DEXTER MD
MD
Internal Medicine Physician
NPI: 1811938434IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
4301(AK)
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration.
PMID 19553387·J Psychopharmacol·2010
7-preclinical
Ergonomic risk associated with assisting in minimally invasive surgery.
PMID 18815838·Surg Endosc·2009
3-trial
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
PMID 19549006·J Neurochem·2009
4-observational
Undifferentiated pancreatic carcinoma with osteoclast-like giant cells: report of a case with osteochondroid differentiation.
PMID 19147301·Pathol Res Pract·2009
5-case
Hydrated vs. freeze-dried human acellular dermal matrix for hernia repair: a comparison in a rabbit model.
PMID 19023639·Hernia·2009
4-observational
Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.
PMID 18482793·Prog Neurobiol·2008
6-review
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
PMID 18365220·Acta Neuropathol·2008
6-review
Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass.
PMID 18374051·Surgery·2008
8-other
Additive neuroprotection by metabotropic glutamate receptor subtype-selective ligands in a rat Parkinson's model.
PMID 18287950·Neuroreport·2008
7-preclinical
Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease.
PMID 17906186·J Am Coll Nutr·2007
7-preclinical
Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
PMID 17012606·J Pharmacol Exp Ther·2007
7-preclinical
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
PMID 17714448·J Neurochem·2007
7-preclinical
Methodological infrastructure in surgical ergonomics: a review of tasks, models, and measurement systems.
PMID 17928614·Surg Innov·2007
6-review
Adaptation of the Medical Research Council Dyspnea Scale and the Oxygen Cost Diagram for its use in Puerto Rico.
PMID 17722426·P R Health Sci J·2007
8-other
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
PMID 17116232·J Neurochem·2007
7-preclinical
Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra.
PMID 17203291·Acta Neuropathol·2007
8-other
Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
PMID 16861952·Transplantation·2006
5-case
Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.
PMID 16699787·Neurogenetics·2006
8-other
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.
PMID 16344956·Neurogenetics·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4315 DIPLOMACY DR
ANCHORAGE, AK 99508 - Phone
- (907) 729-1500
Quick Facts
- NPI
- 1811938434
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile